Exploring the prognosis value, immune correlation, and drug responsiveness prediction of homeobox C6 (HOXC6) in lung adenocarcinoma
2024 · Discover Oncology · 2 citations
https://doi.org/10.1007/s12672-024-01273-w
H
Huajian Peng
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
151
Citations
6
h-index
4
i10-index
Huajian Peng is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: Inflammatory Biomarkers in Disease Prognosis & Lung Cancer Diagnosis and Treatment & Nutrition and Health in Aging. The author has an h-index of 6, co-authored 16 publications.
ORCID: 0000-0001-6423-3581Papers by this author
worksBest Evidence Summary for Perioperative Pain Management in Patients With Pectus Excavatum
2025 · Pain Research and Management · 0 citations
https://doi.org/10.1155/prm/8823617
Clinical outcomes of liposomal and conventional bupivacaine in postoperative pain management in female patients following thoracoscopic lung surgery
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-24214-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat